Is Interleukin 17 (IL-17) Expression A Common Point in the Pathogenesis of Depression and Obesity?
Open Access
- 12 December 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (12), 4018
- https://doi.org/10.3390/jcm9124018
Abstract
(1) Background: Activated immune-inflammatory pathways play an important role in the pathogenesis of depression and pathological obesity. Obesity might promote production of cytokine interleukin 17, which plays a significant role in neuro-immune reactions. The study aimed at assessing the relationship between Body Mass Index (BMI) and IL-17 expression, taking into account the clinical psychiatric variables in patients with depression. (2) Methods: A total of 125 participants took part in the study (95 depressed patients, 30 healthy controls). Data concerning the course of depressive disorders and BMI were collected. The severity of depressive symptoms was assessed using the Hamilton Depression Rating Scale (HDRS). Reverse transcription polymerase chain reaction (RT-PCR) was used to assess IL-17 gene expression at the mRNA levels, while enzyme-linked immunosorbent assay (ELISA) was used to assess IL-17 expression at the protein level. (3) Results: Patients with more hospitalizations showed significantly higher IL-17 mRNA expression levels and higher BMI. However, no correlation between BMI and IL-17 expression was found in depressed patients. (4) Conclusions: Our study revealed that BMI does not affect IL-17 expression in patients with depression. However, further studies should be conducted to evaluate the effects of IL-17 inhibition on adipose tissue and vice versa.Keywords
This publication has 52 references indexed in Scilit:
- Metabolic disturbances connecting obesity and depressionFrontiers in Neuroscience, 2013
- IL-17 in obesity and adipogenesisCytokine & Growth Factor Reviews, 2010
- The economic impact of depression: Resistance or severity?European Neuropsychopharmacology, 2010
- Atypical Depression: Useful Concept, but it's Time to Revise the DSM-IV CriteriaNeuropsychopharmacology, 2009
- Normalization of obesity-associated insulin resistance through immunotherapyNature Medicine, 2009
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Association between obesity and depression in middle-aged womenGeneral Hospital Psychiatry, 2007
- Angiogenesis modulates adipogenesis and obesityJCI Insight, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960